Search

Search Results
Results 8171 - 8180 of 8228 for Skin Cancer
  • Cordilox SR
    Drug - 13 Dec 2022
    Consumer Medicine Information (CMI) about Cordilox SR intended for persons living in Australia.
  • Anpec (new formulation)
    Drug - 13 Dec 2022
    Consumer Medicine Information (CMI) about Anpec (new formulation) intended for persons living in Australia.
  • Pariet 10
    Drug - 12 Dec 2022
    Consumer Medicine Information (CMI) about Pariet 10 (Rabeprazole sodium) intended for persons living in Australia.
  • Alunbrig
    Drug - 7 Dec 2022
    Consumer Medicine Information (CMI) about Alunbrig intended for persons living in Australia.
  • Retrovir
    Drug - 2 Dec 2022
    Consumer Medicine Information (CMI) about Retrovir intended for persons living in Australia.
  • Pariet
    Drug - 2 Dec 2022
    Consumer Medicine Information (CMI) about Pariet (Rabeprazole sodium) intended for persons living in Australia.
  • Stieva-A
    Drug - 2 Dec 2022
    Consumer Medicine Information (CMI) about Stieva-A intended for persons living in Australia.
  • Dilantin
    Drug - 30 Nov 2022
    Consumer Medicine Information (CMI) about Dilantin intended for persons living in Australia.
  • Nuelin-SR
    Drug - 29 Nov 2022
    Consumer Medicine Information (CMI) about Nuelin-SR intended for persons living in Australia.
  • Trumenba
    Drug - 16 Nov 2022
    Consumer Medicine Information (CMI) about Trumenba intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback